Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The development of high-value-added products, expansion of the overseas business, additional measures to address soaring raw material prices and supply chain disruptions, and the transfer of shares in 2 chemical subsidiaries, among other factors.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | ¥216,836 million (YoY +8.7%) |
| Operating profit | ¥20,703 million (YoY +54.7%) |
| Profit attributable to owners of the parent | ¥10,844 million (YoY +12.9%) |
| Net income per share | ¥39.20 |
| Equity ratio | End of the current fiscal period 62.5 / End of previous period 61.1 |
| Total assets | ¥532,799 million |
| Net assets | ¥358,565 million |
| Cash flows from operating activities | ¥9,539 million |
| Cash flows from investing activities | ¥-3,674 million |
| Cash flows from financing activities | ¥-11,209 million |
| Cash and cash equivalents at end of period | ¥83,401 million |
| Full-year earnings forecast | Net Sales ¥430,000 million (YoY +1.9%) / Operating profit ¥40,000 million (YoY +10.0%) / Ordinary income Not disclosed / Net income ¥25,000 million (YoY -9.4%) |
| Annual Dividend Forecast | ¥30 → ¥34(13.3%) |
| Segment revenue | Consumer products business ¥123,646 million (YoY +1.6%), Industrial Products Business ¥27,579 million (YoY -3.9%), Overseas Business ¥100,859 million (YoY +19.7%) |
| Segment profit | Consumer products business ¥9,787 million (YoY +7.1%), Industrial Products Business ¥1,459 million (YoY -0.2%), Overseas Business ¥5,276 million (YoY +66.1%) |
| Regional sales | ¥64,871 million (YoY +25.9%), ¥35,987 million (YoY +10.1%) |
| Depreciation and amortization | ¥11,520 million |
| Impairment loss | ¥122 million |
| Breakdown of extraordinary income (loss) | Not disclosed (the IFRS income statement does not include a separate line item for extraordinary gains or losses) |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New Number of companies 8 / Company name PNB Consolidated Pty Ltd and others / Excluded Number of companies 2 / Company name ライオン・スペシャリティ・ケミカルズ㈱, PT. Ipposha Indonesia |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors, securities analysts and others |
| Issued Shares at Period-End | 279,782,746 |
| Treasury Shares at Period-End | 3,082,287 |
| Factors Behind Changes in Business Performance | The development of high-value-added products, expansion of the overseas business, additional measures to address soaring raw material prices and supply chain disruptions, and the transfer of shares in 2 chemical subsidiaries, among other factors. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited the development of high-value-added products, expansion of its overseas business, and additional measures to address soaring raw material prices and supply chain disruptions. It also completed the transfer of shares in 2 chemical subsidiaries at the end of June.